beta
CXRX
Concordia International Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Concordia International Corp is a specialty pharmaceutical company which owns a diversified portfolio of branded and generic prescription products. It focuses on generic and legacy pharmaceutical products.
Market Cap: 39.1 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.concordiarx.com
Shares Outstanding: 51.3 Million
Float: 51.3 Million
Dividend: 0.0 (0.0%)
Beta: 0.553359
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 693 trading days
From: 2015-09-04 To: 2018-06-07
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|